D

Precision BioSciences

DTIL

9.47400
USD
-0.026
(-0.27%)
Market Closed
Volume
1,364
EPS
0
Div Yield
0
P/E
34
Market Cap
64,452,802
Related Instruments
A
ADPT
-0.13000
(-2.85%)
4.43000 USD
C
CRSP
-2.450
(-4.28%)
54.840 USD
E
EDIT
-0.28500
(-5.26%)
5.13500 USD
N
NSTG
0
(0%)
0.000000 USD
N
NTLA
-1.100
(-4.19%)
25.130 USD
R
RGNX
-0.920
(-6.44%)
13.370 USD
S
SGMO
-0.09690
(-12.11%)
0.70340 USD
T
TECH
0.790
(0.97%)
82.360 USD
V
VYGR
-0.59000
(-6.37%)
8.67000 USD
Z
ZYME
-0.340
(-3.25%)
10.120 USD
News

Title: Precision BioSciences

Sector: Healthcare
Industry: Biotechnology
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.